Maya Beganovic

United States Food and Drug Administration — United States

Immunology and Microbiology · Life Sciences

13h-index702citations56works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotic Use and Resistance(13), Antimicrobial Resistance in Staphylococcus(9), Antibiotics Pharmacokinetics and Efficacy(9), Bacterial Identification and Susceptibility Testing(9), Antibiotic Resistance in Bacteria(4)

Publications56 total

551. A Multistate Investigation of Serious Adverse Events, Including Deaths, Following Ceftriaxone Injections, September 2024–June 2025
Open Forum Infectious Diseases·2026Open Access
Drug-induced enterocolitis syndrome with amoxicillin-containing products: A review of cases reported to the FDA adverse event reporting system and published literature
Journal of Allergy and Clinical Immunology Global·2025· 1 citedOpen Access
The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic
Drug Safety·2022· 12 citedOpen Access
Lactobacillus Endocarditis Complicated by Presumed Vertebral Osteomyelitis and Embolic Stroke
Infectious Diseases in Clinical Practice·2021· 2 cited
Identification of a bacteria-produced benzisoxazole with antibiotic activity against multi-drug resistant Acinetobacter baumannii
The Journal of Antibiotics·2021· 13 citedOpen Access
Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an <i>In Vitro</i> Pharmacodynamic Model
Antimicrobial Agents and Chemotherapy·2020· 57 citedOpen Access
Fluoroquinolone versus Beta-Lactam Oral Step-Down Therapy for Uncomplicated Streptococcal Bloodstream Infections
Antimicrobial Agents and Chemotherapy·2020· 34 citedOpen Access
Impact of Mandatory Infectious Diseases Consultation and Real-time Antimicrobial Stewardship Pharmacist Intervention on Staphylococcus aureus Bacteremia Bundle Adherence
Open Forum Infectious Diseases·2020· 15 citedOpen Access
Clinical Outcomes of Patients Treated for <i>Candida auris</i> Infections in a Multisite Health System, Illinois, USA
Emerging infectious diseases·2020· 49 citedOpen Access
Introduction of Selection Biases Due to Loss to Follow-Up in Infectious Disease Retrospective Outcomes Studies
Antimicrobial Agents and Chemotherapy·2019· 3 citedOpen Access
1041. Staphylococcus aureus Bacteremia Bundle Adherence Pre- and Post-Implementation of Mandatory Infectious Diseases Consultation and Antimicrobial Stewardship Pharmacist Intervention
Open Forum Infectious Diseases·2019· 1 citedOpen Access
1141. Implementation of a Pediatric Handshake Antimicrobial Stewardship Program to Improve Antimicrobial Utilization
Open Forum Infectious Diseases·2019Open Access
1060. Impact of Laboratory Cessation of Extended-Spectrum β-Lactamase (ESBL) Reporting on Minimum Inhibitory Concentration (MIC) Distribution Trends and Associated Clinical Outcomes
Open Forum Infectious Diseases·2019Open Access
Comparison of emergency department to hospital antibiograms: Influence of patient risk factors on susceptibility
The American Journal of Emergency Medicine·2019· 1 cited
Comparative Effectiveness of Exclusive Exposure to Nafcillin or Oxacillin, Cefazolin, Piperacillin/Tazobactam, and Fluoroquinolones Among a National Cohort of Veterans With Methicillin-Susceptible Staphylococcus aureus Bloodstream Infection
Open Forum Infectious Diseases·2019· 40 citedOpen Access
Predictors of Clostridioides difficile recurrence across a national cohort of veterans in outpatient, acute, and long-term care settings
American Journal of Health-System Pharmacy·2019· 27 cited
Biofilm prevention concentrations (BPC) of minocycline compared to polymyxin B, meropenem, and amikacin against Acinetobacter baumannii
Diagnostic Microbiology and Infectious Disease·2019· 22 cited
Reply to Koehler et al
Clinical Infectious Diseases·2019· 1 citedOpen Access
Predictors of Time to Effective and Optimal Antimicrobial Therapy in Patients With Positive Blood Cultures Identified via Molecular Rapid Diagnostic Testing
Open Forum Infectious Diseases·2018· 7 citedOpen Access
Interplay between Rapid Diagnostic Tests and Antimicrobial Stewardship Programs among Patients with Bloodstream and Other Severe Infections
The Journal of Applied Laboratory Medicine·2018· 33 cited
page 1 of 3Next →

Frequent Co-authors

Kerry L. LaPlante(14), Sarah M. Wieczorkiewicz(8), Aisling R. Caffrey(7), Jessica L. Miller(6), Megan K. Luther(5), Erik LaChance(5), Morgan Anderson(5), Jennifer Dela‐Pena(5), Kathryn E Daffinee(4), Kellie Arensman(4), O Ceribasić(4), J Vajzović(4), B Drakulić(4), Anthony Chiang(3), Tristan T. Timbrook(3), Vrishali Lopes(3), A Suljak(3), Marica Šimunović Šoškić(3), Louis B. Rice(2), César A. Arias(2)